Floyd Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$647K Sell
5,359
-17
-0.3% -$1.99K 0.42% 49
2026
Q1
$634K Buy
5,376
+37
+0.7% +$4.27K 0.42% 52
2025
Q4
$653K Buy
5,339
+41
+0.8% +$3.85K 0.44% 52
2025
Q3
$454K Buy
5,298
+409
+8% +$33.7K 0.34% 47
2025
Q2
$396K Sell
4,889
-48
-1% -$3.81K 0.37% 40
2025
Q1
$443K Buy
4,937
+450
+10% +$42K 0.4% 46
2024
Q4
$445K Buy
+4,487
New +$463K 0.37% 51

Other funds holding MRK

Floyd Financial Group's MRK Position: Q2 2026 in Review

Floyd Financial Group reduced its Merck (MRK) stake by 0.32% in Q2 2026, selling an estimated $1.99K and leaving 5,359 shares worth $647K. The position accounts for 0.42% of the portfolio, ranked #49.

Floyd Financial Group first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $653K in Q4 2025. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Floyd Financial Group held 5,359 shares of Merck worth $647K as of Q2 2026.
  • Floyd Financial Group sold 17 Merck shares in Q2 2026, an estimated $1.99K.
  • Merck made up 0.42% of Floyd Financial Group's portfolio in Q2 2026, its #49 holding.
  • Floyd Financial Group first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Floyd Financial Group's Merck position peaked at $653K in Q4 2025.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Floyd Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.